Search
OphtiMedRx
OphtiMed Rx LTD is a preclinical ophthalmic drug development company led by experts in ophthalmology, molecular biology, biotech, out-licensing, and M&As. The company is developing a novel molecular therapy for dry Age-related Macular Degeneration (AMD), a leading cause of blindness affecting millions worldwide. Yet, no effective treatments exist to prevent retinal damage and vision loss. Our drug targets the aging process (cellular senescenc...read more
Source of information:
www.ophtimedrx.com